ArticleJournal of cancer research and clinical oncology2023

ARID1A mutation associated with recurrence and shorter progression-free survival in atypical meningiomas.

Danielle Chaluts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.